SummaryJack Georgakis, diagnosed with aggressive gastroesophageal junction cancer, recovered through a groundbreaking treatment combining chemotherapy with immunotherapy. A global clinical trial showed this approach significantly reduces recurrence and improves survival, offering renewed hope against gastric and oesophageal cancers. This innovative method could transform future cancer treatment and save millions of lives worldwide.